Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.
PMID 42050691 · PMC13126711 · Clinical epigenetics · 2026 · 8 claims · 8 setups
GLYATL1 expression is upregulated in AI-resistant breast cancer cell models and in patients undergoing AI therapy
-
Has reproduction · 65
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.
PMID 36597789 · PMC9906382 · EMBO molecular medicine · 2023 · 8 claims · 8 setups
β-catenin binds directly to promoters of RNA processing, splicing, and ribosomal biogenesis genes in T-ALL cells
-
Full-text index only
Pre-existing cell states predict resistance to multiple treatments.
PMID 41916275 · PMC13261651 · Cell genomics · 2026 · 8 claims · 5 setups
Rare melanoma clones can develop resistance to multiple diverse treatments simultaneously, not just single treatments
-
Full-text index only
EpCAM supports exit from pluripotency of embryonic stem cells via Eomes.
PMID 41963283 · PMC13076738 · Cell death & disease · 2026 · 8 claims · 8 setups
EpCAM supports exit from pluripotency of mESCs and is required for cardiomyocyte formation in embryoid bodies
-
Has reproduction · 68
Identification of new ETV6 modulators through a high-throughput functional screening.
PMID 35198911 · PMC8851229 · iScience · 2022 · 7 claims · 8 setups
A genome-wide shRNA screen in an engineered ETV6-dependent Blasticidin-sensitive pre-B ALL cell line can identify modulators of ETV6 repressive transcriptional activity
-
Full-text index only
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.
PMID 41564866 · PMC12866162 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
CHD1 and MAP3K7 loss additively sensitizes cancer cells to IFN-γ-induced death